Stock Research

More M&A Deals Could Boost Biotech ETFs

By: ETF Trends

Posted on December 11, 2012 at 15:30 PM EST

As drug providers shift away from blockbuster drugs, the biotechnology sector, along with related exchange traded funds, will be supported by the next wave of specialized or targeted drugs. For instance, Amgen (NasdaqGS: AMGN) this week announced a deal to acquire genetic sequencing firm Decode for...

Related Stocks:

First Trust NYSE Arca Biotechnology Index Fund Market Vectors Biotech Etf iShares Nasdaq Biotechnology Index Fund

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates